Search research articles
Contact Us
Filters
Showing results (211-220 of 354) with videos related to
Page
of 36
Sort By:
Cancer Investigation
|
April 28, 2012
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors
Suzanne F Jones, Jeffrey R Infante, David R Spigel, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2016
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors
Jason J Luke, Patricia LoRusso, Geoffrey I Shapiro, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
January 24, 2025
Correlation between metabolic response determined with [<sup>18</sup>F]FDG PET/CT and pathological response after neoadjuvant treatment and surgery in patients with esophageal cancer
J R Infante, J Quirós, R Barco, et al.
Investigational New Drugs
|
April 21, 2017
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
September 18, 2012
[Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan]
J Serrano Vicente, J R Infante Torre, J I Rayo Madrid, et al.
Investigational New Drugs
|
July 6, 2017
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
BMC Cancer
|
March 8, 2017
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
Patricia M LoRusso, Jeffrey R Infante, Kevin B Kim, et al.
Physiology & Behavior
|
March 10, 2001
Catecholamine levels in practitioners of the transcendental meditation technique
J R Infante, M Torres-Avisbal, P Pinel, et al.
Investigational New Drugs
|
October 23, 2014
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer
Johanna C Bendell, Suzanne F Jones, Lowell Hart, et al.
Revista Espanola De Medicina Nuclear
|
June 10, 2006
[Radioguided neurosurgery: a novel application of nuclear medicine]
J Serrano, J I Rayo, J R Infante, et al.
Page
of 36
Search research articles
Search
Showing results (211-220 of 354) with videos related to
Sort By:
Page
of 36
Cancer Investigation
|
April 28, 2012
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors
Suzanne F Jones, Jeffrey R Infante, David R Spigel, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2016
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors
Jason J Luke, Patricia LoRusso, Geoffrey I Shapiro, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
January 24, 2025
Correlation between metabolic response determined with [<sup>18</sup>F]FDG PET/CT and pathological response after neoadjuvant treatment and surgery in patients with esophageal cancer
J R Infante, J Quirós, R Barco, et al.
Investigational New Drugs
|
April 21, 2017
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
September 18, 2012
[Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan]
J Serrano Vicente, J R Infante Torre, J I Rayo Madrid, et al.
Investigational New Drugs
|
July 6, 2017
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
BMC Cancer
|
March 8, 2017
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
Patricia M LoRusso, Jeffrey R Infante, Kevin B Kim, et al.
Physiology & Behavior
|
March 10, 2001
Catecholamine levels in practitioners of the transcendental meditation technique
J R Infante, M Torres-Avisbal, P Pinel, et al.
Investigational New Drugs
|
October 23, 2014
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer
Johanna C Bendell, Suzanne F Jones, Lowell Hart, et al.
Revista Espanola De Medicina Nuclear
|
June 10, 2006
[Radioguided neurosurgery: a novel application of nuclear medicine]
J Serrano, J I Rayo, J R Infante, et al.
Page
of 36